• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER TREVISIO; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER TREVISIO; CATHETER, PERCUTANEOUS Back to Search Results
Model Number 9-ATV07F45/80
Medical Device Problem Codes Retraction Problem (1536); Contamination /Decontamination Problem (2895)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/31/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that on (b)(6) 2023, a 11mm amplatzer septal occluder (aso) was implanted as usual with use of a 7f amplatzer trevisio delivery system.The physician did not encounter any difficulty or resistance with the device implant.After the aso was implanted in the defect, the delivery cable was detached from the aso without any issue.When the delivery cable was being pulled into the trevisio delivery sheath, resistance was felt.After pulling out from the patient, fibrous form like substances was visually confirmed adhering onto 1-2cm of the tip of the delivery cable.The physician alleged that although the aso was able to be detached from the delivery cable as usual, resistance was felt while the delivery cable was pulled into the delivery sheath.So the polyester fiber might have been accidentally tangled by the cable.At present, no findings have been confirmed under echo observation and fluoroscopy of the aso after placement.The product box containing the delivery system did not appeared damaged in any way.Patient stable, no additional information was provided.
 
Additional Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Additional Manufacturer Narrative
An event of resistance being felt while removing the device and a fibrous like substances adhering onto 1-2cm of the tip of the delivery cable was reported.The device was received for analysis which found that a red colored fiber-like material was adherent to the delivery cable.This fiber was sent for analysis and was found to be biological material.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.As the fiber/biological material was found after removal of the device from the patient, it could have come from the patient's body.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER TREVISIO
Common Device Name
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16421119
Report Number2135147-2023-00634
Device Sequence Number6602687
Product Code DQY
UDI-Device Identifier05415067030900
UDI-Public05415067030900
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K190581
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/04/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2024
Device Model Number9-ATV07F45/80
Device Catalogue Number9-ATV07F45/80
Device Lot Number8198172
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/31/2023
Supplement Date Received by Manufacturer04/03/2023
Initial Report FDA Received Date02/22/2023
Supplement Report FDA Received Date04/04/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/28/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
9-ATV0745/80/ LOT#: 8198172).
Patient Age10 YR
Patient SexMale
-
-